HK1080840A1 - Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases - Google Patents
Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseasesInfo
- Publication number
- HK1080840A1 HK1080840A1 HK06100574.8A HK06100574A HK1080840A1 HK 1080840 A1 HK1080840 A1 HK 1080840A1 HK 06100574 A HK06100574 A HK 06100574A HK 1080840 A1 HK1080840 A1 HK 1080840A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- heteroarylcarbonylpiperazines
- arylcarbonylpiperazines
- malignant tumour
- treating benign
- tumour diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39302702P | 2002-06-29 | 2002-06-29 | |
PCT/EP2003/006555 WO2004002965A1 (de) | 2002-06-29 | 2003-06-20 | Aryl- und heteroarylcarbonylpiperazine und deren verwendung zur behandlung gutartiger und bösartiger tumorerkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1080840A1 true HK1080840A1 (en) | 2006-05-04 |
Family
ID=30000964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06100574.8A HK1080840A1 (en) | 2002-06-29 | 2006-01-13 | Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040097734A1 (xx) |
EP (1) | EP1517898A1 (xx) |
JP (1) | JP2005538968A (xx) |
CN (1) | CN100509790C (xx) |
AR (1) | AR040315A1 (xx) |
AU (1) | AU2003246571B2 (xx) |
BR (1) | BR0312294A (xx) |
CA (1) | CA2433983A1 (xx) |
HK (1) | HK1080840A1 (xx) |
HR (1) | HRP20050092A2 (xx) |
MX (1) | MXPA04012959A (xx) |
NO (1) | NO20050428L (xx) |
NZ (1) | NZ537916A (xx) |
PL (1) | PL375527A1 (xx) |
RU (1) | RU2335496C2 (xx) |
UA (1) | UA79286C2 (xx) |
WO (1) | WO2004002965A1 (xx) |
ZA (1) | ZA200409610B (xx) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004218260A1 (en) * | 2003-01-28 | 2004-09-16 | Aventis Pharma S.A. | N-aryl heteroaromatic products, compositions containing same and use thereof |
MXPA05011775A (es) * | 2003-05-01 | 2006-02-17 | Abbott Lab | Sulfonamidas y pirazolamidas como moduladores de canal de sodio. |
PE20050226A1 (es) * | 2003-06-04 | 2005-05-18 | Aventis Pharma Sa | Productos aril-heteroaromaticos y composiciones que los contienen |
FR2855825B1 (fr) * | 2003-06-04 | 2008-08-22 | Aventis Pharma Sa | Produits aryl-heteroaromatiques, compositions les contenant et utilisation |
EP1645556A1 (en) * | 2004-10-07 | 2006-04-12 | Boehringer Ingelheim International GmbH | Arylpiperazine-benzoylamide derivatives useful as pharmaceutical agents |
US7781462B2 (en) | 2005-07-25 | 2010-08-24 | Synta Pharmaceuticals Corp. | Compounds for the treatment of proliferative disorders |
EP2051977A2 (en) * | 2006-07-20 | 2009-04-29 | Amgen Inc. | SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLbeta-HSD-1 |
KR100932093B1 (ko) | 2006-09-27 | 2009-12-16 | 주식회사종근당 | 미세소관 형성 저해제로서 유용한 벤조페논 유도체 |
AU2008288537B2 (en) * | 2007-08-13 | 2011-03-24 | F. Hoffmann-La Roche Ag | Novel piperazine amide derivatives |
CN101597278B (zh) | 2008-06-04 | 2013-04-17 | 中国中化股份有限公司 | 酰胺类化合物及其制备与应用 |
US9212177B2 (en) * | 2009-08-05 | 2015-12-15 | Versitech Limited | Antiviral compounds and methods of making and using thereof |
US20120149715A1 (en) * | 2010-05-28 | 2012-06-14 | Yi Tsun Richard Kao | Compounds and methods for the treatment of viral infections |
KR101369584B1 (ko) * | 2011-04-19 | 2014-03-06 | 일양약품주식회사 | 페닐-이속사졸 유도체 및 그의 제조방법 |
CA3034211A1 (en) * | 2016-08-18 | 2018-02-22 | Vidac Pharma Ltd. | Piperazine derivatives, pharmaceutical compositions and methods of use thereof |
EP3565555A4 (en) * | 2016-11-07 | 2021-03-17 | VIDAC Pharma Ltd. | USE OF HEXKINASE-2 / MITOCHONDRIAL DISCONNECTORS FOR TREATMENT OF HEXKINASE-2 (HC2) EXPRESSING CANCER DISEASES |
WO2018083704A1 (en) | 2016-11-07 | 2018-05-11 | Vidac Pharma Ltd. | Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses |
RU2700576C1 (ru) * | 2019-05-07 | 2019-09-18 | Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") | Анксиолитическое средство |
CN111303132B (zh) * | 2020-03-19 | 2023-05-23 | 辽宁孚音生物科技有限公司 | 一种抗癌化合物及其制备方法和应用 |
CN116322544A (zh) * | 2020-08-12 | 2023-06-23 | 云杉生物科学公司 | 用于治疗多囊卵巢综合征的方法和组合物 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1620016C3 (de) * | 1966-07-02 | 1979-08-30 | Merck Patent Gmbh, 6100 Darmstadt | 3-{Piperazinoalkyl)-pyrazole und Verfahren zu ihrer Herstellung |
US3468882A (en) * | 1966-10-07 | 1969-09-23 | Sterling Drug Inc | Phenylhydrazone derivatives as intermediates for preparing indoles |
BE791501A (fr) * | 1971-11-19 | 1973-05-17 | Albert Ag Chem Werke | Diamines cycliques n,n'-disubstituees et leur procede de preparation |
CA1081228A (en) * | 1976-02-18 | 1980-07-08 | Richard A. Partyka | Oxazole, isoxazole, thiazole and isothiazole amides |
JPS6477A (en) * | 1987-03-24 | 1989-01-05 | Takeda Chem Ind Ltd | 1,4-disubstituted piperazine compound |
EP0385043A1 (en) * | 1989-02-28 | 1990-09-05 | Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. (Faes) | New derivatives of 4-substituted piperazines |
JPH03218371A (ja) * | 1989-08-02 | 1991-09-25 | Takeda Chem Ind Ltd | ピラゾール誘導体 |
US5563142A (en) * | 1989-12-28 | 1996-10-08 | The Upjohn Company | Diaromatic substituted compounds as anti-HIV-1 agents |
EP0552245A1 (en) * | 1990-10-10 | 1993-07-28 | Schering Corporation | Bis-benzo cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use |
DE4219247A1 (de) * | 1992-06-12 | 1993-12-16 | Bayer Ag | Verwendung von 3-arylsubstituierten 5-Alkyl-isoxazol-4-carbonsäurederivaten zur Bekämpfung von Endoparasiten, neue 3-arylsubstituierte 5-Alkyl-isoxazol-4-carbonsäurederivate und Verfahren zu ihrer Herstellung |
WO1994024095A1 (en) * | 1993-04-16 | 1994-10-27 | Abbott Laboratories | Immunosuppressive agents |
US6262059B1 (en) * | 1995-06-07 | 2001-07-17 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with quinazoline derivatives |
WO1998000402A1 (en) * | 1996-06-29 | 1998-01-08 | Samjin Pharmaceutical Co., Ltd. | Piperazine derivatives and process for the preparation thereof |
ES2125206B1 (es) * | 1997-07-21 | 1999-11-16 | Esteve Labor Dr | Derivados de acil-piperazinil-pirimidinas, su preparacion y su aplicacion como medicamentos. |
US6166203A (en) * | 1998-02-26 | 2000-12-26 | Neurogen Corporation | Heterocyclic amino substituted heteroaryl fused pyridines; GABA brain receptor ligands |
KR100659007B1 (ko) * | 1999-02-10 | 2007-02-28 | 미츠비시 웰파마 가부시키가이샤 | 아미드 화합물 및 그 의약으로서의 용도 |
CA2362495A1 (en) * | 1999-03-03 | 2000-09-08 | Theresa M. Williams | Inhibitors of prenyl-protein transferases |
IL148698A0 (en) * | 1999-09-17 | 2002-09-12 | Cor Therapeutics Inc | INHIBITORS OF FACTOR Xa |
DE10035927A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
DE10035908A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
DE10035928A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
AU2001288617A1 (en) * | 2000-09-05 | 2002-03-22 | Neogenesis Pharmaceuticals Inc. | Methods for forming combinatorial libraries combining amide bond formation with epoxide opening |
US20020072081A1 (en) * | 2000-09-06 | 2002-06-13 | Wai-Si Eng | Geranylgeranyl transferase inhibitor screening assay |
FR2815032B1 (fr) * | 2000-10-10 | 2003-08-08 | Pf Medicament | Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations |
DE10102053A1 (de) * | 2001-01-17 | 2002-07-18 | Merck Patent Gmbh | Piperazinylcarbonylchinoline und -isochinoline |
ES2180456B1 (es) * | 2001-07-20 | 2004-05-01 | Laboratorios S.A.L.V.A.T., S.A. | Isoxazoles sustituidos y su utilizacion como antibioticos. |
US6916804B2 (en) * | 2001-12-20 | 2005-07-12 | Osi Pharmaceuticals, Inc. | Pyrimidine A2b selective antagonist compounds, their synthesis and use |
-
2003
- 2003-06-20 MX MXPA04012959A patent/MXPA04012959A/es active IP Right Grant
- 2003-06-20 EP EP03761482A patent/EP1517898A1/de not_active Withdrawn
- 2003-06-20 RU RU2005102478/04A patent/RU2335496C2/ru not_active IP Right Cessation
- 2003-06-20 WO PCT/EP2003/006555 patent/WO2004002965A1/de active IP Right Grant
- 2003-06-20 PL PL03375527A patent/PL375527A1/xx not_active Application Discontinuation
- 2003-06-20 JP JP2004516632A patent/JP2005538968A/ja active Pending
- 2003-06-20 AU AU2003246571A patent/AU2003246571B2/en not_active Ceased
- 2003-06-20 BR BR0312294-8A patent/BR0312294A/pt not_active IP Right Cessation
- 2003-06-20 NZ NZ537916A patent/NZ537916A/en unknown
- 2003-06-20 CN CNB038154854A patent/CN100509790C/zh not_active Expired - Fee Related
- 2003-06-20 UA UA20041210297A patent/UA79286C2/uk unknown
- 2003-06-27 CA CA002433983A patent/CA2433983A1/en not_active Abandoned
- 2003-06-27 AR ARP030102359A patent/AR040315A1/es unknown
- 2003-06-27 US US10/608,520 patent/US20040097734A1/en not_active Abandoned
-
2004
- 2004-11-26 ZA ZA2004/09610A patent/ZA200409610B/en unknown
-
2005
- 2005-01-25 NO NO20050428A patent/NO20050428L/no not_active Application Discontinuation
- 2005-01-27 HR HR20050092A patent/HRP20050092A2/hr not_active Application Discontinuation
-
2006
- 2006-01-13 HK HK06100574.8A patent/HK1080840A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ537916A (en) | 2005-11-25 |
CN100509790C (zh) | 2009-07-08 |
AU2003246571B2 (en) | 2008-06-26 |
HRP20050092A2 (en) | 2005-02-28 |
EP1517898A1 (de) | 2005-03-30 |
PL375527A1 (en) | 2005-11-28 |
RU2335496C2 (ru) | 2008-10-10 |
CN1665792A (zh) | 2005-09-07 |
MXPA04012959A (es) | 2005-05-16 |
WO2004002965A1 (de) | 2004-01-08 |
NO20050428L (no) | 2005-01-25 |
BR0312294A (pt) | 2005-04-12 |
ZA200409610B (en) | 2005-05-25 |
US20040097734A1 (en) | 2004-05-20 |
AU2003246571A1 (en) | 2004-01-19 |
UA79286C2 (en) | 2007-06-11 |
RU2005102478A (ru) | 2005-07-20 |
JP2005538968A (ja) | 2005-12-22 |
CA2433983A1 (en) | 2003-12-29 |
AR040315A1 (es) | 2005-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1080840A1 (en) | Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases | |
HK1086488A1 (en) | Compound and use thereof for the treatment of cancer | |
PL370029A1 (en) | 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer | |
AU2003213144A1 (en) | Alkylating agent combinations in the treatment of cancer | |
AU2003302892A8 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
EP1571968A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMORS | |
HK1072443A1 (en) | Immunoconjugates for the treatment of tumours | |
EP1482970A4 (en) | ANTICANCER THERAPY | |
EP1553912A4 (en) | COMPOSITIONS AND METHODS FOR TUMOR DIAGNOSIS AND TREATMENT | |
HK1078585A1 (en) | Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases | |
HUP0500424A2 (en) | Combination therapy for the treatment of cancer | |
AU2003212634A8 (en) | Compounds useful in the treatment of cancer | |
PL368035A1 (en) | Compositions and methods for the treatment of cancer | |
LT1496918T (lt) | Natrio meta-arsenito naudojimas navikams gydyti | |
AU2003231803A8 (en) | Treatment of cancer with mefloquire | |
GB0226595D0 (en) | Cancer therapy determination | |
AU2002366195A8 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer | |
EP1684795A4 (en) | METHODS AND AGENTS FOR THE TREATMENT OF CANCER | |
IL165440A0 (en) | Arylcarbonylpiperazines and heteroarylpiperazines and the use thereof for treating benign and malignant tumour diseases | |
GB0223325D0 (en) | Treating cancer | |
IL147416A0 (en) | Combined modalities for improved cancer treatment | |
HK1079709A1 (zh) | 脫唾液酸-干擾素系及肝癌的治療 | |
EP1576113A4 (en) | TUMOR ANTIGENS BFA4 AND BCY1 FOR PREVENTING AND / OR TREATING CANCER | |
GB2383538B (en) | Cancer treatment | |
AU2002350513A1 (en) | Use of solasonine for the treatment of skin tumors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20130620 |